Âé¶¹´«Ã½Ó³»­

Âé¶¹´«Ã½Ó³»­

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Retinal biomarkers as a predictor of cognitive performance in progranulin-haploinsufficient frontotemporal dementia
Aging, Dementia, and Behavioral Neurology
Aging and Dementia Posters (7:00 AM-5:00 PM)
026
To investigate optical coherence tomography retinal changes and their clinical relevance in patients with progranulin (GRN) haploinsufficiency.

GRN heterozygous mutations cause progranulin-deficient frontotemporal dementia, an ensemble of age-associated neurodegenerative syndromes presenting predominantly with behavioral abnormalities. Previous investigations suggest neuronal ceroid lipofuscinosis-like features in the retina. Their influence on retinal layer volumes, clinical relevance and utility as biomarkers remains unknown.

We performed optical coherence tomography (OCT) and scanning laser ophthalmoscopy cross-sectionally in 23 GRN haploinsufficient subjects (GRN; age [years, mean+SD]: 62±11, gender [male, N(%)]: 11(48), mean Clinical Dementia Rating(CDR)=0.5; CDR=0.0 for 9 subjects) and 85 healthy controls (HCs) (age [years, mean+SD]: 69±15, gender [male, N(%)]: 42(49)), investigating qualitative and quantitative retinal changes. Mixed-linear effects were used to study the relationships between OCT findings and cognitive performance including design fluency (DF), lexical fluency (LF) and semantic fluency (SF).

Eight GRN eyes (17%) of five subjects (22%) had drusen-like depositions detectable on OCT. Quantifying macular layers, GRN eyes had a thicker outer plexiform layer (OPL, 0.33±0.05mm3, p<0.001), thinner outer nuclear layer (ONL, 0.66±0.07mm3, p=0.019) and thinner retinal pigment epithelium (RPE,0.15±0.02mm3, p=0.039) compared with HC eyes (OPL: 0.30±0.03mm3, ONL: 0.69±0.07mm3, RPE: 0.16±0.01mm3), but no differences in inner retinal layers (replicated without eyes with drusen). GRN subjects with ONL volume<median at baseline, had a faster decline of DF (B=-0.054, SE=0.018, p=0.004), LF (B= - 0.076, SE=0.025, p=0.003) and SF (B=-0.110, SE=0.033, p=0.001) during follow-up compared to subjects with ONL volume≥median. Drusen, OPL and RPE at baseline were not associated with subsequent changes in executive function. Retinal autofluorescence and magnet resonance imaging are pending.

GRN-haploinsufficiency is associated with retinal phenotypes, including drusen and outer retinal layer thinning, suggestive of photoreceptor degeneration. Only ONL volume showed a prognostic value for future cognitive function changes and thereby might be useful as a biomarker.

Authors/Disclosures
Frederike Cosima Oertel, MD (University of California, San Francisco)
PRESENTER
The institution of Dr. Oertel has received research support from Âé¶¹´«Ã½Ó³»­. The institution of Dr. Oertel has received research support from Hertie Foundation. Dr. Oertel has received personal compensation in the range of $500-$4,999 for serving as a Recipient (Travel Grant) with ECTRIMS. Dr. Oertel has received personal compensation in the range of $500-$4,999 for serving as a Recipient (Travel Grant) with NMSS. Dr. Oertel has received personal compensation in the range of $500-$4,999 for serving as a Recipient (Travel Grant) with ACTRIMS.
Kyan Younes, MD (Stanford School of Medicine) Dr. Younes has nothing to disclose.
No disclosure on file
Daniel Bennett (UCSF School Of Medicine) No disclosure on file
No disclosure on file
Shivany Condor Montes (Sandler Neurosciences Center) No disclosure on file
Ari Green, MD (UCSF) Dr. Green has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for JAMA Neurology. The institution of Dr. Green has received research support from Department of Defense. The institution of Dr. Green has received research support from Department of Defense. The institution of Dr. Green has received research support from NIH. The institution of Dr. Green has received research support from NIH / NINDS. The institution of Dr. Green has received research support from NIH / NINDS. Dr. Green has received intellectual property interests from a discovery or technology relating to health care.
Fanny M. Elahi, MD, PhD Dr. Elahi has nothing to disclose.